Search Within

Population Sciences Research Program

  1. "Jedd Wolchok"
  2. "Sloan Kettering Institute Faculty"
Formats
  1. Journal Article (19)
  2. Meeting Abstract (6)
Groups
  1. Department of Medicine (25)
  2. GSK Faculty (25)
  3. Melanoma and Immunotherapeutics Service (25)
  4. Sloan Kettering Institute Faculty (25)
  5. Solid Tumor Oncology Division (25)
  6. Biostatistics Service (22)

More Groups

People
  1. Jedd Wolchok (25)
  2. Katherine Panageas (22)
  3. Alan Houghton (18)
  4. Paul Chapman (15)
  5. Jianda Yuan (10)
  6. Susan Krown (8)

More People

Years
  1. 2022 (1)
  2. 2021 (1)
  3. 2018 (2)
  4. 2017 (1)
  5. 2013 (4)
  6. 2011 (1)

More Years

Publications
  1. Clinical Cancer Research (5)
  2. Cancer Research (3)
  3. Journal of Investigative Dermatology (3)
  4. Cancer (2)
  5. Molecular Therapy (2)
  6. Blood (1)

More Publications

Publishers
  1. American Association for Cancer Research (10)
  2. Elsevier Science, Inc. (3)
  3. Nature Publishing Group (2)
  4. Wiley Blackwell (2)
  5. Academy of Cancer Immunology (1)
  6. American Association for the Advancement of Science (1)

More Publishers

Results (25)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Increased p53 expression induced by APR-246 reprograms tumor-associated macrophages to augment immune checkpoint blockade
    Journal Article

    Ghosh, A.; Michels, J.; Mezzadra, R.; Venkatesh, D.; Dong, L.; Gomez, R.; Samaan, F.; Ho, Y. J.; Campesato, L. F.; Mangarin, L.; more...
    Journal of Clinical Investigation (2022)

    Fulltext@MSK | Save
  • Therapeutic implications of detecting MAPK-activating alterations in cutaneous and unknown primary melanomas
    Journal Article

    Shoushtari, A. N.; Chatila, W. K.; Arora, A.; Sanchez-Vega, F.; Kantheti, H. S.; Rojas Zamalloa, J. A.; Krieger, P.; Callahan, M. K.; Betof Warner, A.; Postow, M. A.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Adipocyte-derived lipids mediate melanoma progression via FATP proteins
    Journal Article

    Zhang, M.; Di Martino, J. S.; Bowman, R. L.; Campbell, N. R.; Baksh, S. C.; Simon-Vermot, T.; Kim, I. S.; Haldeman, P.; Mondal, C.; Yong-Gonzales, V.; more...
    Cancer Discovery (2018)

    Fulltext@MSK | Save
  • Robust antitumor responses result from local chemotherapy and CTLA-4 blockade
    Journal Article

    Ariyan, C. E.; Brady, M. S.; Siegelbaum, R. H.; Hu, J.; Bello, D. M.; Rand, J.; Fisher, C.; Lefkowitz, R. A.; Panageas, K. S.; Pulitzer, M.; more...
    Cancer Immunology Research (2018)

    Fulltext@MSK | Save
  • Blockade of surface-bound TGF-ß on regulatory T cells abrogates suppression of effector T cell function in the tumor microenvironment
    Journal Article

    Budhu, S.; Schaer, D. A.; Li, Y.; Toledo-Crow, R.; Panageas, K.; Yang, X.; Zhong, H.; Houghton, A. N.; Silverstein, S. C.; Merghoub, T.; more...
    Science Signaling (2017)

    Fulltext@MSK | Save
  • Immunologic responses to xenogeneic tyrosinase DNA vaccine administered by electroporation in patients with malignant melanoma
    Journal Article

    Yuan, J.; Ku, G. Y.; Adamow, M.; Mu, Z.; Tandon, S.; Hannaman, D.; Chapman, P.; Schwartz, G.; Carvajal, R.; Panageas, K. S.; more...
    Journal for ImmunoTherapy of Cancer (2013)

    Fulltext@MSK | Save
  • Phase II trial of MEK inhibitor selumetinib (AZD6244) in patients with BRAFV600E/K- or NRAS-mutated melanoma
    Meeting Abstract

    Catalanotti, F.; Solit, D. B.; Pulitzer, M. P.; Berger, M. F.; Scott, S. N.; Iyriboz, T.; Lacouture, M. E.; Panageas, K. S.; Wolchok, J. D.; Carvajal, R. D.; more...
    Cancer Research (2013)

    Fulltext@MSK | Save
  • Eradication of melanoma by intratumoral injection of attenuated vaccinia virus requires CD8+ T cells and combination of anti-CTLA-4 blockade and virotherapy enhances therapeutic efficacy in advanced melanoma
    Meeting Abstract

    Wu, X.; Dai, P.; Wang, W.; Avogadri, F.; Cao, H.; Parikh, T.; Jiang, X.; Halpern, A. C.; Houghton, A. N.; Shuman, S.; more...
    Journal of Investigative Dermatology (2013)

    Fulltext@MSK | Save
  • Phase II trial of MEK inhibitor selumetinib (AZD6244, ARRY-142886) in patients with BRAFV600E/K-mutated melanoma
    Journal Article

    Catalanotti, F.; Solit, D. B.; Pulitzer, M. P.; Berger, M. F.; Scott, S. N.; Iyriboz, T.; Lacouture, M. E.; Panageas, K. S.; Wolchok, J. D.; Carvajal, R. D.; more...
    Clinical Cancer Research (2013)

    Fulltext@MSK | Save
  • Peptide-loaded langerhans cells, despite increased IL15 secretion and T-cell activation in vitro, elicit antitumor T-cell responses comparable to peptide-loaded monocyte-derived dendritic cells in vivo
    Journal Article

    Romano, E.; Rossi, M.; Ratzinger, G.; De Cos, M. A.; Chung, D. J.; Panageas, K. S.; Wolchok, J. D.; Houghton, A. N.; Chapman, P. B.; Heller, G.; more...
    Clinical Cancer Research (2011)

    Fulltext@MSK | Save